Revolution Medicines, Inc.
NASDAQ · us_market
No AI insight generated yet for this ticker.
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291) which is in early clinical development for the treatment of solid tumors, and zoldonrasib G12D (RMC-9805), which are in phase 3 registrational trial evaluating the combination of daraxonrasib with zoldonrasib in patients with 1L PDAC; and development candidates comprise RMC-5127 (G12V) which is in clinical trial, RMC-0708 (Q61H), that is in clinical trial; and RMC-8839 (G13C). Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| FidelityFMR | fundamental | 8.46M | $823.15M | 0.04% | Trimmed-1.4% | 2026-03-31 |
| Wellington | fundamental | 6.03M | $586.21M | 0.11% | Trimmed-13.7% | 2026-03-31 |
| StateStreet | passive | 4.40M | $428.16M | 0.01% | Added+7.1% | 2026-03-31 |
| TwoSigma | quant | 1.56M | $151.59M | 0.12% | Added+269.6% | 2026-03-31 |
| DEShaw | quant | 1.02M | $99.42M | 0.06% | Trimmed-36.6% | 2026-03-31 |
| RenTech | quant | 6.2K | $602.95K | 0.00% | New | 2026-03-31 |
| TRowePrice | fundamental | 3.23M | $314.33K | 0.04% | Trimmed-5.1% | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-05upcoming | -2.03 | — | — |
| 2026-05-06 | -1.84 | -2.29 | -24.61% |
| 2026-02-25 | -1.58 | -1.86 | -17.59% |
| 2025-11-05 | -1.41 | -1.61 | -14.34% |
| 2025-08-06 | -1.12 | -1.31 | -16.74% |
| 2025-05-07 | -1.06 | -1.13 | -7.02% |
| 2025-02-26 | -0.96 | -1.12 | -16.12% |
| 2024-11-06 | -0.88 | -0.94 | -7.00% |
| 2024-08-07 | -0.76 | -0.81 | -6.29% |
| 2024-05-08 | -0.72 | -0.70 | +2.49% |
| 2024-02-26 | -0.88 | -1.14 | -30.32% |
| 2023-11-06 | -1.00 | -0.99 | +1.00% |
| 2023-08-08 | -0.82 | -0.92 | -12.00% |
| 2023-05-08 | -0.80 | -0.72 | +9.79% |
| 2023-02-27 | -0.81 | -0.63 | +22.06% |
| 2022-11-07 | -0.85 | -0.87 | -2.56% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| RVMD | +12.91% | +55.63% | +97.71% | +287.40% |
| XLV | +2.97% | -4.83% | -3.44% | +12.62% |
| Alpha (stock − sector) | +9.94% | +60.45% | +101.16% | +274.78% |